No impact of NOD2/CARD15 on outcome after SCT

Bone Marrow Transplantation

Volumn 41, Issue 11, 2008, Pages 961-964

  Sairafi, D ^a,b   Uzunel, M ^b   Remberger, M ^b   Ringden O ^a,b   Mattsson, J ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DONOR SELECTION; FEMALE; GENE MUTATION; HETEROZYGOSITY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HAPLOTYPES; HUMANS; LEUKEMIA; LYMPHOMA; MALE; MIDDLE AGED; MYELODYSPLASTIC-MYELOPROLIFERATIVE DISEASES; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 45449120866     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.9     Document Type: Article

References (15)

1. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, Belaiche J et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411: 599-603.
2. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-606.
3. Eckmann L, Karin M. NOD2 and Crohn's disease: Loss or gain of function? Immunity 2005; 22: 661-667.
4. Holler E, Rogler G, Herfarth H, Brenmoehl J, Wild PJ, Hahn JH et al Both donor and recipient NOD2/CARD15 mutations associate with transplant-related mortality and GvHD following allogeneic stem cell transplantation. Blood 2004; 104: 889-894.
5. Holler E, Rogler G, Brenmoehl J, Hahn J, Herfarth H, Greinix H et al Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: Effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination. Blood 2006; 107 4189-4193.
6. Elmaagacli AH, Koldehoff M, Hindahl H, Steckel NK, Trenschel R, Peceny R et al. Mutations in innate immune system NOD2/CARD 15 and TLR-4 (Thr399Ile) genes influence the risk for severe acute graft-versus-host disease in patients who underwent an allogeneic transplantation. Transplantation 2006; 81: 247-254.
7. Svahn BM, Remberger M, Myrbäck KE, Holmberg K, Eriksson B, Hentschke P et al. Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared to hospital care. Blood 2002; 100: 4317-4324.
8. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2h: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992; 39: 225-235.
9. Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974; 18: 295-304.
10. Hampe J, Grebe J, Nikolaus S, Solberg C, Croucher PJ, Mascheretti S et al. Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: A cohort study. Lancet 2002; 359: 1661-1665.
11. Mattsson J, Uzunel M, Remberger M, Ringdén O. T-cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation. Transplantation 2001; 71: 433-439.
12. Ringdén O, Remberger M, Persson U, Ljungman P, Aldener A, Andström E et al. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings. Bone Marrow Transplant 1995; 15: 619-625.
13. Granell M, Urbano-Ispizua A, Aróstegui JI, Fernández-Avilés F, Martínez C, Rovira M et al. Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation. Haematologica 2006; 91: 1372-1376.
14. Oh H, Loberiza Jr FR, Zhang MJ, Ringdén O, Akiyama H, Asai T et al Comparison of graft-vs-host disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations. Blood 2005; 105: 1408-1416.
15. Remberger M, Aschan J, Lönnqvist B, Carlens S, Gustafsson B, Hentschke P et al. An ethnic role for chronic, but not acute graft-versus-host disease after HLA-identical sibling stem cell transplantation. Eur J Haematol 2001; 66: 50-56.